DOJ Signals Heightened Scrutiny on Information Exchanges and Competitor Collaborations

WHAT HAPPENED On February 3, 2023, the US Department of Justice’s (DOJ) Antitrust Division announced the withdrawal of three policy statements related to antitrust enforcement in healthcare. Although the withdrawn statements focus on healthcare, DOJ’s decision to withdraw these statements will have broad impacts across industries. The three policy statements, issued in 1993, 1996, and 2011, relate to competitor collaboration […]
The post DOJ Signals Heightened Scrutiny on Information Exchanges and Competitor Collaborations appeared first on ANTITRUST ALERT .